2016
DOI: 10.1016/j.antiviral.2016.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral activity of selected flavonoids against Chikungunya virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
74
0
5

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
3
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 132 publications
(83 citation statements)
references
References 30 publications
0
74
0
5
Order By: Relevance
“…Fisetin possessed post-infection anti-CHIKV activity by the inhibition of NS proteins 1 and 3 in a dose-dependent manner. Moreover, it was observed that CHIKV E2 protein and its precursor pE2 were also downregulated during treatment with fisetin [21]. Similarly, a decreased replication process of DENV-2 was observed when Vero cells were treated with fisetin after DENV-2 infection.…”
Section: Flavonoids Against Non-picornavirusesmentioning
confidence: 95%
“…Fisetin possessed post-infection anti-CHIKV activity by the inhibition of NS proteins 1 and 3 in a dose-dependent manner. Moreover, it was observed that CHIKV E2 protein and its precursor pE2 were also downregulated during treatment with fisetin [21]. Similarly, a decreased replication process of DENV-2 was observed when Vero cells were treated with fisetin after DENV-2 infection.…”
Section: Flavonoids Against Non-picornavirusesmentioning
confidence: 95%
“…The inhibition of hepatitis C virus and the human (2016), Gómez-Calderón et al (2017) cytomegalovirus (HCMV) infection was done by the activity of quercetagetin (Zakaryan et al 2017). Moreover, baicalein, quercetagetin, and fisetin were also reported for the inhibition of chikungunya virus by impeding the intracellular viral replication at early stages (Lani et al 2016). Phenolic acids have shown significant antiviral activity against HSV-1 very significantly (Medini et al 2016).…”
Section: Flavonoids As Antiviral Agentsmentioning
confidence: 99%
“…These data provide the first evidence of the intracellular anti-CHIKV activities of these compounds [68]. The CHIKV replicon cell line, BHKCHIKV-NCT, was validated and used for screening 356 compounds, including 123 natural compounds and 233 clinically approved drugs and other pharmaceutical compounds.…”
Section: Indirect Inhibitory Activities Of Compounds and Extracts Agamentioning
confidence: 90%